{"gene":"COX4I1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2007,"finding":"HIF-1 reciprocally regulates COX4-1 and COX4-2 isoform expression in response to hypoxia: under low O2, HIF-1 activates transcription of COX4-2 and LON (a mitochondrial protease required for COX4-1 degradation), thereby switching subunit composition to optimize respiration efficiency. Manipulating COX4 isoform expression alters COX activity, ATP production, O2 consumption, and ROS generation.","method":"Transcriptional reporter assays, siRNA knockdown, overexpression, O2 consumption and ATP measurement, ROS assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (transcription, proteolysis, functional metabolic assays) in a high-impact study, independently cited >900 times","pmids":["17418790"],"is_preprint":false},{"year":2007,"finding":"Yeast Cox4 (ortholog of human COX4I1) binds Zn(II) via a single His and three conserved Cys residues; Cys-ligand substitutions abolish cytochrome oxidase assembly, demonstrating that Zn(II) binding is required for structural stability of the complex. NMR solution structure reveals a C-terminal globular domain with two β-sheets, the Zn buried within.","method":"NMR structure determination, site-directed mutagenesis of Zn-coordinating residues, yeast complementation / growth assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure plus mutagenesis with functional (assembly) readout","pmids":["17215247"],"is_preprint":false},{"year":2006,"finding":"Translation of yeast COX4 is repressed in the absence of phosphatidylglycerol and cardiolipin (pgs1Δ mutant). A 50-nucleotide fragment with two stem-loops in the 5′-UTR acts as a cis-element inhibiting COX4 translation; a cytoplasmic protein factor specifically binds this element in pgs1Δ cells, linking mitochondrial lipid composition to nuclear-gene translational control.","method":"mtGFP reporter fusions, 5′-UTR deletion analysis, RNA-binding protein pulldown from cytoplasmic extracts, genetic complementation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (reporter, deletion, protein-binding) with rigorous genetic controls","pmids":["16428432"],"is_preprint":false},{"year":2009,"finding":"Polyamines (spermidine) stimulate COX4 translation in yeast by promoting ribosome shunting over stem-loop (hairpin) structures in the COX4 mRNA 5′-UTR, identifying COX4 as the first member of the yeast 'polyamine modulon'.","method":"Polyamine-requiring spe1Δ mutant rescue, polysome profiling, 5′-UTR reporter assays","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic model plus translational reporter, single lab","pmids":["19695341"],"is_preprint":false},{"year":2017,"finding":"A K101N missense mutation in human COX4I1 causes decreased COX activity, impaired ATP production, elevated ROS, and undetectable COX4-1 protein in patient fibroblasts; lentiviral transduction with wild-type COX4I1 restored COX activity and ATP production, establishing COX4I1 as the first nuclear-encoded subunit whose mutation causes human mitochondrial disease via COX deficiency.","method":"Whole-exome sequencing, Sanger confirmation, enzymatic activity assays, ATP measurement, ROS assay, lentiviral complementation","journal":"European journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — patient mutation plus functional rescue by wild-type gene, multiple biochemical readouts","pmids":["28766551"],"is_preprint":false},{"year":2017,"finding":"Chlorpromazine selectively inhibits cytochrome c oxidase (CcO) activity in chemoresistant glioma cells expressing COX4-1 but not in chemosensitive cells expressing COX4-2, and computer-docking shows tighter binding to COX4-1-containing CcO. COX4-1-expressing cells undergo selective cell-cycle arrest with chlorpromazine treatment in orthotopic mouse models.","method":"CcO enzymatic activity assays, in silico docking, cell cycle analysis, orthotopic mouse brain tumor model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2/3 — enzymatic assay plus in vivo model, docking is computational; single lab","pmids":["28455961"],"is_preprint":false},{"year":2021,"finding":"Complete knockout of COX4I1 (COX4 subunit) in HEK293 cells abolishes complex IV (cIV) and causes profound deficiency of complex I (cI), reducing cI subunit levels and assembled cI. Pulse-chase metabolic labeling shows decreased mitochondrial translation of both cIV and cI subunits, and complexome profiling reveals accumulation of cI assembly intermediates, indicating that COX4I1 loss impairs mitochondrial protein synthesis and cI biogenesis.","method":"CRISPR/Cas9 knockout, BN-PAGE complexome profiling, pulse-chase 35S-metabolic labeling of mtDNA-encoded proteins, Western blotting of OXPHOS subunits","journal":"Cells","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (pulse-chase labeling, complexome profiling, KO) in a single rigorous study","pmids":["33578848"],"is_preprint":false},{"year":2020,"finding":"Dynein light chain 1 (Dynll1) forms a persistent complex with mitochondrial Cox4i1; pathogen insult (Listeria monocytogenes) dissociates this complex, and dissociation is required for release of mitochondrial ROS that restrict intracellular bacterial proliferation. Thus Dynll1 acts as an inhibitor of mitochondrial ROS through its interaction with Cox4i1.","method":"Mass spectrometry of membrane proteins, co-immunoprecipitation, Listeria infection model in dendritic cells, ROS measurement","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2/3 — Co-IP plus functional infectious model, single lab","pmids":["32041786"],"is_preprint":false},{"year":2022,"finding":"COX4-1 expression promotes assembly of CcO-containing mitochondrial supercomplexes (SCs) in GBM cells and reduces superoxide production; overexpression of COX4-1 in radiosensitive cells is sufficient to shift metabolism from glycolytic to oxidative and confer radioresistance, while silencing in radioresistant cells disassembles SCs and increases superoxide.","method":"Isogenic GBM cell lines (COX4-1 OE / silencing), BN-PAGE for supercomplex analysis, Seahorse metabolic profiling, ROS measurement, clonogenic radiation survival assay","journal":"Cell stress","confidence":"High","confidence_rationale":"Tier 2 — gain- and loss-of-function with multiple metabolic and structural readouts, isogenic pairs","pmids":["35478774"],"is_preprint":false},{"year":2018,"finding":"HIF-1α regulates the COXIV-1/COXIV-2 ratio in neurons following microwave-induced mitochondrial ROS production: HIF-1α inhibition down-regulates COX4I1 expression, impairs mitochondrial membrane potential and ATP production, and increases ROS, indicating HIF-1α maintains COX4I1 levels as a protective response.","method":"In vivo microwave exposure model, HIF-1α inhibitor treatment, luciferase reporter for HIF-1α transcriptional activity, Western blot, ATP and ROS measurement, MMP assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2/3 — pharmacological HIF-1α inhibition with functional metabolic readouts, single lab","pmids":["29991768"],"is_preprint":false},{"year":2021,"finding":"miR-338 directly targets COX4I1; inhibition of miR-338 increases COX4I1 protein and CcO activity, improving ATP production and cell survival after ischemia/glucose deprivation in astrocytes and neurons. Concurrent siRNA knockdown of COX4I1 abolishes the protective effect, placing COX4I1 downstream of miR-338 in the ischemic injury pathway.","method":"miR-338 antagomir/mimic in vivo (MCAO model) and in vitro, CcO activity assay, ATP measurement, siRNA epistasis experiment, infarct size measurement","journal":"Mitochondrion","confidence":"High","confidence_rationale":"Tier 2 — in vivo plus in vitro with genetic epistasis (siRNA rescue experiment) confirming COX4I1 as the effector","pmids":["33933660"],"is_preprint":false},{"year":2024,"finding":"COX4I1 depletion in EVT trophoblast cells inhibits proliferation, increases migration and invasion, impairs mitochondrial respiration and glycolysis, and promotes mitochondrial fusion; MMP1 knockdown rescues the increased migration/invasion caused by COX4I1 silencing, placing MMP1 downstream of COX4I1 in trophoblast invasion control.","method":"siRNA knockdown, RTCA proliferation/migration/invasion assay, EdU, MitoTracker staining, Seahorse metabolic analysis, siRNA epistasis (MMP1)","journal":"Placenta","confidence":"Medium","confidence_rationale":"Tier 2/3 — multiple functional assays plus epistasis, single lab","pmids":["38718733"],"is_preprint":false},{"year":2022,"finding":"COX4-1 deficiency leads to replicative stress and impaired nuclear DNA damage response: patient fibroblasts and COX4I1-knockdown cells accumulate DNA damage preferentially in proliferating cells, show reduced DNA damage response pathway expression, impaired recovery from genotoxic insult, and decreased DNA repair capacity, leading to premature senescence.","method":"Patient fibroblasts (COX4I1 mutation), siRNA knockdown, γH2AX immunofluorescence, DNA damage response gene expression, genotoxin recovery assay","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2/3 — patient cells corroborated by KD model, multiple assays, single lab","pmids":["35456968"],"is_preprint":false},{"year":2024,"finding":"CRISPR screen identified COX4I1 as a vulnerability in AML; COX4I1 depletion induces mitochondrial stress and ferroptosis, disrupts mitochondrial ultrastructure and OXPHOS, and synergizes with venetoclax. CRISPR tiling scans coupled with mitochondrial proteomics identified critical regions within COX4I1 essential for complex IV assembly.","method":"Cell signaling-focused CRISPR screen, COX4I1 KO/depletion, mitochondrial proteomics, CRISPR gene tiling, in vivo AML xenograft, drug synergy assay (venetoclax + chlorpromazine)","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 2 — orthogonal CRISPR approaches, proteomics, in vivo model, drug combination with functional readouts","pmids":["39716856"],"is_preprint":false},{"year":2018,"finding":"Human cytochrome c oxidase complex IV contains 14 subunits; cryo-EM structure at 3.3 Å of the human supercomplex I1III2IV1 assigned NDUFA4 as a subunit of complex IV occupying the dimeric interface, demonstrating that the intact complex IV is a monomer. COX4I1 (subunit IV-1) is resolved as part of the complete structure.","method":"Cryo-EM structure determination at 3.3 Å from human supercomplex","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure of the intact human complex IV","pmids":["30030519"],"is_preprint":false},{"year":2012,"finding":"COX4I1 (as an early-assembling, presequence-containing subunit) is integrated into cytochrome c oxidase assembly intermediates (MITRAC complexes) via TIM21, which links the TIM23 mitochondrial presequence translocase to respiratory-chain assembly; loss of TIM21 impairs integration of COX4I1-containing subunits into assembly intermediates and regulates mitochondrial protein synthesis in response to assembly state.","method":"Comprehensive co-IP/AP-MS of COX assembly intermediates, TIM21 knockdown, pulse-chase metabolic labeling, BN-PAGE","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — AP-MS plus genetic (KD) plus metabolic labeling, multiple orthogonal methods","pmids":["23260140"],"is_preprint":false},{"year":2025,"finding":"Arachidonoyl-phosphatidylethanolamine (AA-PE), accumulated in brown adipose tissue mitochondria during cold stress via LPCAT3, partitions at the COX4I1 interface of cytochrome c oxidase; lipid-based proteomics, MD simulations, and bioenergetic analyses show this interaction enhances electron transport chain efficiency and is required for respiratory-dependent thermogenesis.","method":"Lipid-based proteomics, molecular dynamics simulations, bioenergetic (ETC) analysis, fat-specific Lpcat3-KO mice, cold acclimation model","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal approaches but preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.05.15.654206"],"is_preprint":true},{"year":2025,"finding":"COX4I1-expressing (transmitochondrial) cybrid cells reconstituted with COX4-1-containing mitochondria restore CcO activity and confer resistance to erastin-induced ferroptosis, instead undergoing apoptosis; COX4-1 cybrids exhibit reduced labile iron, diminished cystine uptake, and low SLC7A11/GPX4 expression, demonstrating that mitochondrial COX4-1 rewires redox metabolism and diverts cell-death signaling from ferroptosis to apoptosis.","method":"CRISPR POLG-KO ρ0 cells, transmitochondrial cybrid reconstitution, CcO activity assay, cell death mode analysis, iron measurement, cystine uptake, Western blot for SLC7A11/GPX4","journal":"Antioxidants","confidence":"High","confidence_rationale":"Tier 1-2 — cybrid reconstitution isolates mitochondrial from nuclear contributions, multiple orthogonal mechanistic readouts","pmids":["41596099"],"is_preprint":false},{"year":2011,"finding":"Cytochrome c oxidase (COX) activity and COX4 protein levels are regulated by reversible phosphorylation downstream of cAMP/PKA and tyrosine kinase signaling, linking cell signaling pathways to COX activity, mitochondrial membrane potential, and ROS/ATP production; identified phosphorylation sites on COX subunits including COX4I1.","method":"Phosphoproteomic analysis of COX, kinase/signaling inhibitor studies, crystal-structure mapping of phosphorylation sites","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2/3 — phosphoproteomics plus structural mapping and signaling inhibitors; COX4I1-specific phosphorylation data partially inferred from broader COX analysis","pmids":["21771582"],"is_preprint":false},{"year":2025,"finding":"A de novo nonsense COX4I1 variant in trans with a deep intronic variant (causing frameshift) primarily reduces COX4I1 protein levels, impairing complex IV assembly and activity. Proteomic analysis of patient fibroblasts also revealed decreased levels of mitoribosomal proteins, suggesting COX4I1 deficiency secondarily affects mitochondrial ribosome homeostasis.","method":"Short- and long-read NGS, functional studies in patient tissues and transfected cell lines, complex IV activity assay, mitochondrial proteomics","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 2 — functional validation in patient cells with molecular and proteomic data, single case","pmids":["41203052"],"is_preprint":false}],"current_model":"COX4I1 encodes the ubiquitous regulatory subunit 4 isoform 1 of mitochondrial cytochrome c oxidase (complex IV); it is essential for complex IV assembly and stability (via zinc coordination in yeast ortholog and early MITRAC-complex integration in humans), optimizes respiratory efficiency through HIF-1-controlled isoform switching (COX4-1 vs. COX4-2) in response to oxygen availability, promotes mitochondrial supercomplex assembly to limit ROS production, interacts with Dynll1 to gate mitochondrial ROS release during bacterial infection, is translationally regulated by mitochondrial lipid composition and polyamines via 5′-UTR stem-loop elements, is targeted by miR-338, and is modulated by AA-PE lipid interaction at its interface on complex IV; loss of COX4I1 causes complex IV deficiency, secondary complex I biogenesis impairment through reduced mitochondrial protein synthesis, replicative stress with impaired DNA damage response, and in cancer cells COX4-1 expression rewires redox metabolism to shift cell death from ferroptosis toward apoptosis."},"narrative":{"teleology":[{"year":2006,"claim":"Establishing that COX4 translation is controlled by mitochondrial lipid composition resolved how nuclear-encoded respiratory subunit expression responds to organelle state, revealing a 5′-UTR stem-loop cis-element and a trans-acting cytoplasmic repressor protein active in cardiolipin-deficient yeast.","evidence":"Reporter fusions, 5′-UTR deletion mapping, and RNA-binding protein pulldown in pgs1Δ yeast","pmids":["16428432"],"confidence":"High","gaps":["Identity of the cytoplasmic RNA-binding repressor protein was not determined","Whether this translational regulation operates in mammalian cells is unknown"]},{"year":2007,"claim":"Demonstrating that HIF-1 coordinately activates COX4-2 and the LON protease to degrade COX4-1 under hypoxia established the first oxygen-responsive isoform-switching mechanism for a respiratory chain subunit, directly linking subunit composition to ATP yield and ROS output.","evidence":"Transcriptional reporters, siRNA, overexpression, O₂ consumption, ATP, and ROS assays in mammalian cells","pmids":["17418790"],"confidence":"High","gaps":["Tissue-specific kinetics and thresholds of the isoform switch in vivo are incompletely defined","Whether post-translational modifications modulate the switching efficiency is unresolved"]},{"year":2007,"claim":"Solving the NMR structure of yeast Cox4 and showing that Zn(II) coordination by conserved Cys/His residues is essential for complex IV assembly provided the first structural basis for the subunit's role in enzyme stability.","evidence":"NMR solution structure, site-directed mutagenesis of Zn-ligand residues, yeast complementation","pmids":["17215247"],"confidence":"High","gaps":["Whether Zn coordination is functionally conserved in human COX4I1 has not been directly tested by mutagenesis","No high-resolution structure of the isolated human COX4I1 subunit exists"]},{"year":2012,"claim":"Identifying COX4I1 as an early-assembling subunit integrated via TIM21-mediated coupling of the TIM23 translocase to MITRAC assembly intermediates explained how mitochondrial import is coordinated with respiratory chain biogenesis.","evidence":"AP-MS of COX assembly intermediates, TIM21 knockdown, pulse-chase metabolic labeling, BN-PAGE in human cells","pmids":["23260140"],"confidence":"High","gaps":["Chaperones or factors that specifically stabilize COX4I1 after import but before MITRAC integration are uncharacterized","Structural details of the COX4I1–MITRAC interaction interface are unknown"]},{"year":2017,"claim":"Identification of the first pathogenic COX4I1 mutation (K101N) in a patient with cytochrome c oxidase deficiency, rescued by wild-type complementation, established COX4I1 as a Mendelian disease gene for mitochondrial complex IV deficiency.","evidence":"Whole-exome sequencing, enzymatic and metabolic assays, lentiviral rescue in patient fibroblasts","pmids":["28766551"],"confidence":"High","gaps":["Genotype–phenotype spectrum across additional COX4I1 variants is limited to very few patients","Mechanism by which K101N specifically destabilizes the protein (beyond loss of detectable COX4-1) is unresolved"]},{"year":2018,"claim":"The 3.3-Å cryo-EM structure of the human respiratory supercomplex I₁III₂IV₁ placed COX4I1 within the complete 14-subunit complex IV architecture and confirmed that functional complex IV is monomeric within the supercomplex.","evidence":"Cryo-EM of purified human mitochondrial supercomplex","pmids":["30030519"],"confidence":"High","gaps":["How COX4-1 versus COX4-2 incorporation structurally alters the supercomplex interface is not resolved","Dynamic conformational changes of COX4I1 during the catalytic cycle are unknown"]},{"year":2020,"claim":"Discovery that Dynll1 forms a persistent complex with Cox4i1 and that pathogen-induced dissociation releases mitochondrial ROS to restrict intracellular Listeria revealed an unexpected innate-immune signaling role for complex IV subunit interactions.","evidence":"Mass spectrometry, co-immunoprecipitation, Listeria infection in dendritic cells, ROS measurement","pmids":["32041786"],"confidence":"Medium","gaps":["Reciprocal validation (e.g., Cox4i1 bait pulling down Dynll1) and structural mapping of the interaction site are lacking","Whether this mechanism operates for other intracellular pathogens is unknown","How pathogen signals trigger dissociation of the Dynll1–Cox4i1 complex is unresolved"]},{"year":2021,"claim":"CRISPR knockout of COX4I1 demonstrated that its loss not only abolishes complex IV but secondarily impairs complex I biogenesis and mitochondrial translation, revealing an unexpected trans-complex dependency in OXPHOS assembly.","evidence":"CRISPR KO in HEK293, BN-PAGE complexome profiling, 35S pulse-chase metabolic labeling","pmids":["33578848"],"confidence":"High","gaps":["Whether the complex I defect is caused by reduced mitoribosomal function or a specific assembly factor feedback is undefined","Applicability across tissues and in vivo models remains untested"]},{"year":2022,"claim":"Showing that COX4-1 expression drives supercomplex assembly and limits superoxide in glioblastoma cells, conferring radioresistance, linked respiratory chain structural organization to cancer therapy response and identified COX4-1 as a metabolic determinant of treatment sensitivity.","evidence":"Isogenic COX4-1 overexpression/silencing, BN-PAGE supercomplex analysis, Seahorse profiling, clonogenic radiation survival","pmids":["35478774"],"confidence":"High","gaps":["Mechanism by which COX4-1 preferentially promotes supercomplex formation over COX4-2 is unknown","In vivo validation of supercomplex-dependent radioresistance is limited"]},{"year":2022,"claim":"Demonstrating that COX4-1-deficient cells accumulate replication-associated DNA damage, show impaired DNA damage response, and enter premature senescence extended COX4I1's role beyond bioenergetics to genome maintenance.","evidence":"Patient fibroblasts and siRNA knockdown, γH2AX immunofluorescence, genotoxin recovery, DDR gene expression","pmids":["35456968"],"confidence":"Medium","gaps":["Whether the DNA damage phenotype is a direct consequence of elevated ROS or reduced nucleotide synthesis is unresolved","Single-lab observation awaiting independent confirmation"]},{"year":2024,"claim":"A CRISPR screen identifying COX4I1 as an AML vulnerability, with depletion inducing ferroptosis and synergizing with venetoclax, positioned COX4I1-dependent respiration as a druggable node in leukemia and mapped critical assembly-essential regions by gene tiling.","evidence":"CRISPR dropout screen, gene tiling, mitochondrial proteomics, in vivo AML xenograft, venetoclax synergy","pmids":["39716856"],"confidence":"High","gaps":["Whether the ferroptosis phenotype is specific to AML or generalizable across hematologic malignancies is untested","Optimal therapeutic window for pharmacological COX4-1 inhibition has not been defined"]},{"year":2025,"claim":"Transmitochondrial cybrid reconstitution showed that COX4-1-containing mitochondria rewire redox metabolism—reducing labile iron and suppressing SLC7A11/GPX4—to divert cell death from ferroptosis toward apoptosis, separating mitochondrial from nuclear contributions to this effect.","evidence":"CRISPR POLG-KO ρ0 cells, cybrid reconstitution, CcO activity, cell death mode analysis, iron and cystine uptake assays","pmids":["41596099"],"confidence":"High","gaps":["Signaling pathway linking COX4-1-dependent respiration to SLC7A11/GPX4 down-regulation is uncharacterized","Whether the ferroptosis–apoptosis switch is isoform-specific (COX4-1 vs. COX4-2) under matched conditions is not fully resolved"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for differential supercomplex assembly by COX4-1 versus COX4-2, the signaling mechanism linking COX4I1 loss to impaired mitochondrial translation and complex I biogenesis, and whether pharmacological targeting of COX4-1-dependent respiration can be therapeutically exploited without on-target toxicity.","evidence":"","pmids":[],"confidence":"Low","gaps":["No isoform-resolved cryo-EM structure comparing COX4-1 and COX4-2 supercomplexes exists","Mechanism coupling COX4I1 deficiency to mitoribosomal protein depletion is undefined","Therapeutic index for COX4-1 pharmacological inhibition in cancer versus normal tissue is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[1,6,14,15]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,4,8,14]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1,6,14,15,16]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,6,8,14]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,9,12]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[6,15]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[13,17]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,13,19]}],"complexes":["Cytochrome c oxidase (complex IV)","Respiratory supercomplex I1III2IV1","MITRAC assembly intermediate"],"partners":["DYNLL1","TIM21","COX4I2","NDUFA4"],"other_free_text":[]},"mechanistic_narrative":"COX4I1 encodes the ubiquitous isoform 1 of subunit 4 of mitochondrial cytochrome c oxidase (complex IV), serving as a nuclear-encoded regulatory subunit essential for complex IV assembly, stability, and respiratory efficiency. Under normoxia COX4-1 is the predominant isoform; hypoxia triggers HIF-1-dependent transcriptional activation of COX4-2 and LON-mediated degradation of COX4-1, switching subunit composition to optimize ATP production and limit ROS [PMID:17418790]. COX4-1 promotes assembly of respiratory supercomplexes, and its complete loss abolishes complex IV, secondarily impairs complex I biogenesis and mitochondrial translation, causes replicative stress with defective DNA damage repair, and in cancer cells rewires redox metabolism to favor apoptosis over ferroptosis [PMID:33578848, PMID:35478774, PMID:35456968, PMID:41596099]. Biallelic loss-of-function mutations in COX4I1 cause cytochrome c oxidase deficiency presenting as mitochondrial disease, confirmed by lentiviral rescue of enzymatic activity in patient fibroblasts [PMID:28766551]."},"prefetch_data":{"uniprot":{"accession":"P13073","full_name":"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial","aliases":["Cytochrome c oxidase polypeptide IV","Cytochrome c oxidase subunit IV isoform 1","COX IV-1"],"length_aa":169,"mass_kda":19.6,"function":"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/P13073/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/COX4I1","classification":"Not Classified","n_dependent_lines":348,"n_total_lines":1208,"dependency_fraction":0.28807947019867547},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2},{"gene":"RAC1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/COX4I1","total_profiled":1310},"omim":[{"mim_id":"620634","title":"IMMUNITY-RELATED GTPase CINEMA; IRGC","url":"https://www.omim.org/entry/620634"},{"mim_id":"619060","title":"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16","url":"https://www.omim.org/entry/619060"},{"mim_id":"618855","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44; COXPD44","url":"https://www.omim.org/entry/618855"},{"mim_id":"617465","title":"SMALL INTEGRAL MEMBRANE PROTEIN 20; SMIM20","url":"https://www.omim.org/entry/617465"},{"mim_id":"612322","title":"FAST KINASE DOMAINS 2; FASTKD2","url":"https://www.omim.org/entry/612322"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/COX4I1"},"hgnc":{"alias_symbol":["COX4-1","COXIV","COXIV-1"],"prev_symbol":["COX4"]},"alphafold":{"accession":"P13073","domains":[{"cath_id":"1.10.442.10","chopping":"35-93","consensus_level":"medium","plddt":95.3131,"start":35,"end":93},{"cath_id":"-","chopping":"129-169","consensus_level":"medium","plddt":96.4273,"start":129,"end":169}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13073","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13073-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13073-F1-predicted_aligned_error_v6.png","plddt_mean":88.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=COX4I1","jax_strain_url":"https://www.jax.org/strain/search?query=COX4I1"},"sequence":{"accession":"P13073","fasta_url":"https://rest.uniprot.org/uniprotkb/P13073.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13073/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13073"}},"corpus_meta":[{"pmid":"28455961","id":"PMC_28455961","title":"Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28455961","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25731709","id":"PMC_25731709","title":"Male obesity is associated with changed spermatozoa Cox4i1 mRNA level and altered seminal vesicle fluid composition in a mouse model.","date":"2015","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/25731709","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28766551","id":"PMC_28766551","title":"Mutation in the COX4I1 gene is associated with short stature, poor weight gain and increased chromosomal breaks, simulating Fanconi anemia.","date":"2017","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/28766551","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33578848","id":"PMC_33578848","title":"Loss of COX4I1 Leads to Combined Respiratory Chain Deficiency and Impaired Mitochondrial Protein Synthesis.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33578848","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2174427","id":"PMC_2174427","title":"Isolation and characterization of QCR9, a nuclear gene encoding the 7.3-kDa subunit 9 of the Saccharomyces cerevisiae ubiquinol-cytochrome c oxidoreductase complex. An intron-containing gene with a conserved sequence occurring in the intron of COX4.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2174427","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18564841","id":"PMC_18564841","title":"Noncovalent interactions under extreme conditions: high-pressure and low-temperature diffraction studies of the isostructural metal-organic networks (4-chloropyridinium)2[CoX4] (X = Cl, Br).","date":"2008","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/18564841","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17215247","id":"PMC_17215247","title":"The characterization and role of zinc binding in yeast Cox4.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17215247","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32911610","id":"PMC_32911610","title":"Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32911610","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16428432","id":"PMC_16428432","title":"Translational regulation of nuclear gene COX4 expression by mitochondrial content of phosphatidylglycerol and cardiolipin in Saccharomyces cerevisiae.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16428432","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19695341","id":"PMC_19695341","title":"Polyamine modulon in yeast-Stimulation of COX4 synthesis by spermidine at the level of translation.","date":"2009","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19695341","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29991768","id":"PMC_29991768","title":"HIF-1α regulates COXIV subunits, a potential mechanism of self-protective response to microwave induced mitochondrial damages in neurons.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29991768","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3033605","id":"PMC_3033605","title":"The untranslated leader of nuclear COX4 gene of Saccharomyces cerevisiae contains an intron.","date":"1987","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/3033605","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31290619","id":"PMC_31290619","title":"Biallelic variants in COX4I1 associated with a novel phenotype resembling Leigh syndrome with developmental regression, intellectual disability, and seizures.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/31290619","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35478774","id":"PMC_35478774","title":"COX4-1 promotes mitochondrial supercomplex assembly and limits reactive oxide species production in radioresistant GBM.","date":"2022","source":"Cell stress","url":"https://pubmed.ncbi.nlm.nih.gov/35478774","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33058529","id":"PMC_33058529","title":"COXIV and SIRT2-mediated G6PD deacetylation modulate ROS homeostasis to extend pupal lifespan.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/33058529","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32041786","id":"PMC_32041786","title":"The Dynll1-Cox4i1 Complex Regulates Intracellular Pathogen Clearance via Release of Mitochondrial Reactive Oxygen Species.","date":"2020","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32041786","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10337626","id":"PMC_10337626","title":"The 5' region of the COX4 gene contains a novel overlapping gene, NOC4.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10337626","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33933660","id":"PMC_33933660","title":"MicroRNA-338 inhibition protects against focal cerebral ischemia and preserves mitochondrial function in vitro in astrocytes and neurons via COX4I1.","date":"2021","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/33933660","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20878365","id":"PMC_20878365","title":"The cardiac copper chaperone proteins Sco1 and CCS are up-regulated, but Cox 1 and Cox4 are down-regulated, by copper deficiency.","date":"2010","source":"Biological trace element research","url":"https://pubmed.ncbi.nlm.nih.gov/20878365","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38718733","id":"PMC_38718733","title":"Cytochrome c oxidase IV isoform 1 (COX4-1) regulates the proliferation, migration and invasion of trophoblast cells via modulating mitochondrial function.","date":"2024","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/38718733","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35456968","id":"PMC_35456968","title":"Replicative Stress Coincides with Impaired Nuclear DNA Damage Response in COX4-1 Deficiency.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35456968","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28148493","id":"PMC_28148493","title":"Subfunctionalization of COX4 paralogs in fish.","date":"2017","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28148493","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35327978","id":"PMC_35327978","title":"COX4-like, a Nuclear-Encoded Mitochondrial Gene Duplicate, Is Essential for Male Fertility in Drosophila melanogaster.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35327978","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24351431","id":"PMC_24351431","title":"Leptin stimulation of COXIV is impaired in obese skeletal muscle myotubes.","date":"2007","source":"Obesity research & clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/24351431","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36497016","id":"PMC_36497016","title":"Destabilizing COXIV in Müller Glia Increases Retinal Glycolysis and Alters Scotopic Electroretinogram.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36497016","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39716856","id":"PMC_39716856","title":"Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39716856","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30393577","id":"PMC_30393577","title":"Comparison of Pre- and Post-translational Expressions of COXIV-1 and MT-ATPase 6 Genes in Colorectal Adenoma-Carcinoma Tissues.","date":"2018","source":"Journal of carcinogenesis & mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30393577","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27471277","id":"PMC_27471277","title":"Evaluating the role of NRF-1 in the regulation of the goldfish COX4-1 gene in response to temperature.","date":"2016","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27471277","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12215857","id":"PMC_12215857","title":"Cloning of COX4 cDNA from the NZ white rabbit and expression of this gene in bladder smooth muscle following partial outlet obstruction.","date":"2002","source":"World journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/12215857","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40095452","id":"PMC_40095452","title":"Compound heterozygosity of a De novo 16q24.1 deletion and missense mutation in COX4I1 leads to developmental regression, intellectual disability, and seizures.","date":"2025","source":"Epilepsia open","url":"https://pubmed.ncbi.nlm.nih.gov/40095452","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41203052","id":"PMC_41203052","title":"Complex IV deficiency due to COX4I1 deep intronic and de novo variants results in progressive motor impairment and Leigh syndrome.","date":"2025","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/41203052","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40958887","id":"PMC_40958887","title":"The Nuclear-Encoded Cytochrome c Oxidase Subunit COX4-1 Enhances Hypoxia Tolerance in Glioblastoma Cells.","date":"2025","source":"Journal of oncology research and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40958887","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41596099","id":"PMC_41596099","title":"Cytochrome c Oxidase Subunit COX4-1 Reprograms Erastin-Induced Cell Death from Ferroptosis to Apoptosis: A Transmitochondrial Study.","date":"2025","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/41596099","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.25.661655","title":"Pharmacological inhibition of G protein-coupled receptor kinase 5 decreases high-fat diet-induced hepatic steatosis in mice","date":"2025-06-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.25.661655","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.15.654206","title":"A cold-inducible phospholipid—protein interaction in brown fat mitochondria optimizes thermogenic capacity","date":"2025-05-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.15.654206","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17418790","id":"PMC_17418790","title":"HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17418790","citation_count":996,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22190034","id":"PMC_22190034","title":"Global landscape of HIV-human protein complexes.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22190034","citation_count":593,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22119785","id":"PMC_22119785","title":"Defining human ERAD networks through an integrative mapping strategy.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22119785","citation_count":427,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31056398","id":"PMC_31056398","title":"Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.","date":"2019","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/31056398","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32838362","id":"PMC_32838362","title":"Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.","date":"2020","source":"Med (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32838362","citation_count":291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36369321","id":"PMC_36369321","title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36369321","citation_count":259,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21771582","id":"PMC_21771582","title":"Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21771582","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23260140","id":"PMC_23260140","title":"MITRAC links mitochondrial protein translocation to respiratory-chain assembly and translational regulation.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/23260140","citation_count":196,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30030519","id":"PMC_30030519","title":"Structure of the intact 14-subunit human cytochrome c oxidase.","date":"2018","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30030519","citation_count":175,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25544563","id":"PMC_25544563","title":"Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25544563","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18811,"output_tokens":4138,"usd":0.059251},"stage2":{"model":"claude-opus-4-6","input_tokens":7602,"output_tokens":3931,"usd":0.204428},"total_usd":0.542548,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":30823,"output_tokens":5116,"usd":0.084604},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8927,"output_tokens":3395,"usd":0.194265}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Yeast Cox4 (ortholog of COX4I1) binds zinc via a single histidine and three conserved cysteine residues; substitution of cysteine ligands abolishes cytochrome c oxidase assembly, and NMR solution structure reveals a C-terminal globular domain with two beta-sheets, demonstrating that Zn(II) binding is required for structural stability of the complex.\",\n      \"method\": \"NMR structure determination, site-directed mutagenesis of zinc-coordinating residues, cytochrome c oxidase assembly assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure combined with mutagenesis and functional assembly assays in a single study\",\n      \"pmids\": [\"17215247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Translation of yeast COX4 is repressed in cells lacking phosphatidylglycerol and cardiolipin; a 50-nucleotide cis-element with two stem-loops in the COX4 5' UTR mediates translational repression, and a trans-acting protein factor from cardiolipin-deficient cytoplasm specifically binds this element.\",\n      \"method\": \"Reporter gene (mtGFP) fusion with 5' UTR deletion analysis, RNA-binding assay with cytoplasmic extracts, genetic complementation with PGS1\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — deletion mapping of cis-element, RNA–protein binding assay, genetic rescue, multiple orthogonal methods\",\n      \"pmids\": [\"16428432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In yeast, spermidine stimulates COX4 synthesis at the level of translation by facilitating ribosome shunting over stem-loop structures in the COX4 5'-UTR, making COX4 the first member of the polyamine modulon in yeast.\",\n      \"method\": \"Polyamine-requiring yeast mutant rescue, metabolic labeling, 5'-UTR reporter assays\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with translational reporter, single lab\",\n      \"pmids\": [\"19695341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A homozygous K101N mutation in COX4I1 in a patient causes decreased COX activity, impaired ATP production, elevated ROS, and undetectable COX4I1 protein in fibroblasts; lentiviral transfection with wild-type COX4I1 restored COX activity and ATP production, confirming COX4I1 as an essential regulatory subunit of complex IV.\",\n      \"method\": \"Patient fibroblast biochemical assays (COX activity, ATP production, ROS), lentiviral rescue with wild-type COX4I1, Sanger sequencing\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical rescue experiment in patient cells with multiple functional readouts\",\n      \"pmids\": [\"28766551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Chlorpromazine selectively inhibits cytochrome c oxidase activity in glioma cells expressing COX4I1 (COX4-1 isoform) but not in cells expressing COX4-2; computer-docking studies showed tighter chlorpromazine binding to CcO containing COX4-1, and selective cell cycle arrest occurs only in COX4-1-expressing cells.\",\n      \"method\": \"Enzymatic complex IV activity assay, computer-simulated docking, cell cycle analysis, patient-derived glioma stem cells, orthotopic mouse tumor model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — enzymatic assay with isoform-selective pharmacology, supported by in silico docking and in vivo model\",\n      \"pmids\": [\"28455961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Complete knockout of COX4I1 (COX4 subunit) in HEK293 cells eliminates complex IV, secondarily causes profound complex I deficiency (decreased cI subunit levels and assembled cI), and impairs mitochondrial protein synthesis correlated with decreased mitoribosomal protein content; complexome profiling showed accumulation of cI assembly intermediates, indicating cIV is required for cI biogenesis.\",\n      \"method\": \"CRISPR/Cas9 knockout, blue-native PAGE complexome profiling, pulse-chase metabolic labeling of mtDNA-encoded proteins, Western blot for OXPHOS subunits\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — complete genetic KO with multiple orthogonal biochemical readouts including complexome profiling and metabolic labeling\",\n      \"pmids\": [\"33578848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"COX4-1 (COX4I1) promotes assembly of CcO-containing mitochondrial supercomplexes in GBM cells; overexpression of COX4-1 in radiosensitive cells switches metabolism from glycolytic to oxidative and reduces superoxide production, while silencing COX4-1 in radioresistant cells disassembles supercomplexes and increases superoxide, demonstrating COX4-1 is sufficient to drive supercomplex assembly and ROS regulation.\",\n      \"method\": \"COX4-1 overexpression and siRNA silencing in isogenic GBM cell lines, Blue-native PAGE for supercomplex assessment, Seahorse respirometry, superoxide measurement, patient-derived xenolines\",\n      \"journal\": \"Cell stress\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with multiple orthogonal readouts in isogenic lines\",\n      \"pmids\": [\"35478774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Dynein light chain 1 (Dynll1) forms a persistent complex with mitochondrial cytochrome oxidase Cox4i1; dissociation of the Dynll1-Cox4i1 complex upon Listeria monocytogenes infection is required for the release of mitochondrial reactive oxygen species that restrict intracellular bacterial proliferation.\",\n      \"method\": \"Mass spectrometry of membrane protein complexes, Co-immunoprecipitation, genetic depletion of Dynll1, mitochondrial ROS measurement, intracellular bacterial proliferation assay in dendritic cells\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — MS-identified complex confirmed by Co-IP with functional ROS and bactericidal readouts, single lab\",\n      \"pmids\": [\"32041786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-338 directly targets COX4I1; inhibition of miR-338 increases COX4I1 levels, augments cytochrome c oxidase activity and ATP production in astrocytes and neurons, and protection conferred by miR-338 inhibitor against ischemic stress is abolished by concurrent siRNA knockdown of COX4I1.\",\n      \"method\": \"miR-338 antagomir treatment in vivo (MCAO mouse model), siRNA knockdown of COX4I1, CcO activity assay, ATP measurement, cell survival assay\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via double KD (miR-338 inhibitor + COX4I1 siRNA) with defined functional rescue in multiple cell types\",\n      \"pmids\": [\"33933660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HIF-1α regulates COX4I1 (COXIV-1) expression; HIF-1α inhibition downregulates COXIV-1, promotes ROS generation, impairs mitochondrial membrane potential, and abolishes microwave-induced ATP production, indicating HIF-1α→COXIV-1 is a protective axis maintaining mitochondrial function.\",\n      \"method\": \"HIF-1α inhibitor treatment in neuron-like cells, ROS measurement, mitochondrial membrane potential assay, ATP production assay, in vivo microwave-exposed animal model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis with multiple mitochondrial functional readouts, single lab\",\n      \"pmids\": [\"29991768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"COX4I1 depletion in AML cells induces mitochondrial stress and ferroptosis, disrupts mitochondrial ultrastructure and oxidative phosphorylation; CRISPR gene tiling and mitochondrial proteomics identified critical regions within COX4I1 essential for Complex IV assembly; pharmacological inhibition of Complex IV (chlorpromazine) synergizes with venetoclax.\",\n      \"method\": \"CRISPR screen, COX4I1 CRISPR gene tiling, mitochondrial proteomics, electron microscopy of mitochondrial ultrastructure, Seahorse respirometry, venetoclax combination assay, in vivo AML mouse model\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — CRISPR tiling with proteomics identifies functional domains, multiple orthogonal readouts including in vivo validation\",\n      \"pmids\": [\"39716856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"COX4I1 loss-of-function in patient fibroblasts and knockdown cells causes replicative stress and impaired nuclear DNA damage response; COX4-1-deficient cells showed reduced expression of DNA damage response pathway genes, impaired recovery from genotoxic insult, and decreased DNA repair.\",\n      \"method\": \"Patient fibroblast analysis, COX4I1 siRNA knockdown, expression profiling of DNA damage response genes, genotoxic challenge and recovery assay, proliferating cell marker analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — patient cells plus KD model with functional DNA repair assays, single lab\",\n      \"pmids\": [\"35456968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"COX4I1 knockdown in trophoblast (EVT) cells inhibits proliferation, increases migration and invasion, impairs mitochondrial respiration and glycolysis, and induces mitochondrial fusion; MMP1 knockdown rescues the increased migration and invasion caused by COX4I1 silencing, placing MMP1 downstream of COX4I1 in controlling EVT invasiveness.\",\n      \"method\": \"siRNA knockdown, real-time cell analysis (RTCA), EdU proliferation assay, MitoTracker staining, Seahorse bioenergetics, MMP1 double-knockdown epistasis\",\n      \"journal\": \"Placenta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via double KD placing MMP1 downstream, multiple functional readouts, single lab\",\n      \"pmids\": [\"38718733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"COX4I1 variants abolish COX4I1 protein, impairing Complex IV assembly and activity; proteomic data from patient fibroblasts also indicate downregulation of mitoribosomal proteins, suggesting COX4I1 deficiency affects mitoribosome levels in addition to Complex IV function.\",\n      \"method\": \"Patient fibroblast studies, transiently transfected cell lines, short/long read next-generation sequencing, functional complex IV activity assays, mitochondrial proteomics\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional rescue and proteomics in patient tissues, single lab\",\n      \"pmids\": [\"41203052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Using CRISPR-generated rho-zero (ρ0) cells and transmitochondrial cybrids reconstituted with COX4-1- or COX4-2-containing mitochondria, COX4-1 mitochondria restore CcO activity and confer resistance to erastin-induced ferroptosis, diverting cell death toward apoptosis; COX4-1 cybrids exhibit reduced labile iron, diminished cystine uptake, and low SLC7A11/GPX4 expression, demonstrating that isoform-specific mitochondrial COX4 composition rewires redox metabolism and cell-death pathway selection.\",\n      \"method\": \"CRISPR POLG-KO ρ0 cells, transmitochondrial cybrid reconstitution, erastin ferroptosis assay, labile iron pool measurement, cystine uptake assay, Western blot for SLC7A11 and GPX4\",\n      \"journal\": \"Antioxidants (Basel, Switzerland)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — transmitochondrial cybrid reconstitution isolates mitochondrial contribution, multiple orthogonal mechanistic readouts\",\n      \"pmids\": [\"41596099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Arachidonoyl-phosphatidylethanolamine (AA-PE), whose accumulation in brown adipose tissue mitochondria is driven by the cold-regulated acyltransferase LPCAT3, partitions at the COX4I1 interface of the cytochrome c oxidase complex and enhances electron transport chain efficiency, demonstrating a specific lipid–COX4I1 protein interaction that optimizes thermogenic capacity.\",\n      \"method\": \"Lipid-based proteomics, molecular dynamics simulations, Lpcat3 fat-specific knockout mice, bioenergetic analysis of BAT mitochondria\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — MD simulations + lipid proteomics + KO mouse phenotype; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.05.15.654206\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"COX4I1 encodes the housekeeping isoform (COX4-1) of cytochrome c oxidase subunit 4, an essential regulatory subunit of mitochondrial Complex IV (CcO) that binds zinc to stabilize the complex, is required for CcO assembly and activity, promotes assembly of CcO-containing mitochondrial supercomplexes (thereby limiting superoxide production), is required for normal mitochondrial protein synthesis and Complex I biogenesis, is regulated at the translational level by cardiolipin/phosphatidylglycerol and by polyamines (via 5'-UTR stem-loop structures), is transcriptionally regulated by HIF-1α, is targeted by miR-338, forms a functional complex with Dynll1 whose dissociation gates mitochondrial ROS release for pathogen clearance, interacts at its protein interface with arachidonoyl-PE to enhance electron transport efficiency, and its isoform identity (COX4-1 vs COX4-2) determines CcO kinetic properties, supercomplex incorporation, ROS levels, and cell-death pathway selection between ferroptosis and apoptosis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"HIF-1 reciprocally regulates COX4-1 and COX4-2 isoform expression in response to hypoxia: under low O2, HIF-1 activates transcription of COX4-2 and LON (a mitochondrial protease required for COX4-1 degradation), thereby switching subunit composition to optimize respiration efficiency. Manipulating COX4 isoform expression alters COX activity, ATP production, O2 consumption, and ROS generation.\",\n      \"method\": \"Transcriptional reporter assays, siRNA knockdown, overexpression, O2 consumption and ATP measurement, ROS assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (transcription, proteolysis, functional metabolic assays) in a high-impact study, independently cited >900 times\",\n      \"pmids\": [\"17418790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Yeast Cox4 (ortholog of human COX4I1) binds Zn(II) via a single His and three conserved Cys residues; Cys-ligand substitutions abolish cytochrome oxidase assembly, demonstrating that Zn(II) binding is required for structural stability of the complex. NMR solution structure reveals a C-terminal globular domain with two β-sheets, the Zn buried within.\",\n      \"method\": \"NMR structure determination, site-directed mutagenesis of Zn-coordinating residues, yeast complementation / growth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure plus mutagenesis with functional (assembly) readout\",\n      \"pmids\": [\"17215247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Translation of yeast COX4 is repressed in the absence of phosphatidylglycerol and cardiolipin (pgs1Δ mutant). A 50-nucleotide fragment with two stem-loops in the 5′-UTR acts as a cis-element inhibiting COX4 translation; a cytoplasmic protein factor specifically binds this element in pgs1Δ cells, linking mitochondrial lipid composition to nuclear-gene translational control.\",\n      \"method\": \"mtGFP reporter fusions, 5′-UTR deletion analysis, RNA-binding protein pulldown from cytoplasmic extracts, genetic complementation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (reporter, deletion, protein-binding) with rigorous genetic controls\",\n      \"pmids\": [\"16428432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Polyamines (spermidine) stimulate COX4 translation in yeast by promoting ribosome shunting over stem-loop (hairpin) structures in the COX4 mRNA 5′-UTR, identifying COX4 as the first member of the yeast 'polyamine modulon'.\",\n      \"method\": \"Polyamine-requiring spe1Δ mutant rescue, polysome profiling, 5′-UTR reporter assays\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model plus translational reporter, single lab\",\n      \"pmids\": [\"19695341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A K101N missense mutation in human COX4I1 causes decreased COX activity, impaired ATP production, elevated ROS, and undetectable COX4-1 protein in patient fibroblasts; lentiviral transduction with wild-type COX4I1 restored COX activity and ATP production, establishing COX4I1 as the first nuclear-encoded subunit whose mutation causes human mitochondrial disease via COX deficiency.\",\n      \"method\": \"Whole-exome sequencing, Sanger confirmation, enzymatic activity assays, ATP measurement, ROS assay, lentiviral complementation\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient mutation plus functional rescue by wild-type gene, multiple biochemical readouts\",\n      \"pmids\": [\"28766551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Chlorpromazine selectively inhibits cytochrome c oxidase (CcO) activity in chemoresistant glioma cells expressing COX4-1 but not in chemosensitive cells expressing COX4-2, and computer-docking shows tighter binding to COX4-1-containing CcO. COX4-1-expressing cells undergo selective cell-cycle arrest with chlorpromazine treatment in orthotopic mouse models.\",\n      \"method\": \"CcO enzymatic activity assays, in silico docking, cell cycle analysis, orthotopic mouse brain tumor model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — enzymatic assay plus in vivo model, docking is computational; single lab\",\n      \"pmids\": [\"28455961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Complete knockout of COX4I1 (COX4 subunit) in HEK293 cells abolishes complex IV (cIV) and causes profound deficiency of complex I (cI), reducing cI subunit levels and assembled cI. Pulse-chase metabolic labeling shows decreased mitochondrial translation of both cIV and cI subunits, and complexome profiling reveals accumulation of cI assembly intermediates, indicating that COX4I1 loss impairs mitochondrial protein synthesis and cI biogenesis.\",\n      \"method\": \"CRISPR/Cas9 knockout, BN-PAGE complexome profiling, pulse-chase 35S-metabolic labeling of mtDNA-encoded proteins, Western blotting of OXPHOS subunits\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (pulse-chase labeling, complexome profiling, KO) in a single rigorous study\",\n      \"pmids\": [\"33578848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Dynein light chain 1 (Dynll1) forms a persistent complex with mitochondrial Cox4i1; pathogen insult (Listeria monocytogenes) dissociates this complex, and dissociation is required for release of mitochondrial ROS that restrict intracellular bacterial proliferation. Thus Dynll1 acts as an inhibitor of mitochondrial ROS through its interaction with Cox4i1.\",\n      \"method\": \"Mass spectrometry of membrane proteins, co-immunoprecipitation, Listeria infection model in dendritic cells, ROS measurement\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — Co-IP plus functional infectious model, single lab\",\n      \"pmids\": [\"32041786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"COX4-1 expression promotes assembly of CcO-containing mitochondrial supercomplexes (SCs) in GBM cells and reduces superoxide production; overexpression of COX4-1 in radiosensitive cells is sufficient to shift metabolism from glycolytic to oxidative and confer radioresistance, while silencing in radioresistant cells disassembles SCs and increases superoxide.\",\n      \"method\": \"Isogenic GBM cell lines (COX4-1 OE / silencing), BN-PAGE for supercomplex analysis, Seahorse metabolic profiling, ROS measurement, clonogenic radiation survival assay\",\n      \"journal\": \"Cell stress\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with multiple metabolic and structural readouts, isogenic pairs\",\n      \"pmids\": [\"35478774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HIF-1α regulates the COXIV-1/COXIV-2 ratio in neurons following microwave-induced mitochondrial ROS production: HIF-1α inhibition down-regulates COX4I1 expression, impairs mitochondrial membrane potential and ATP production, and increases ROS, indicating HIF-1α maintains COX4I1 levels as a protective response.\",\n      \"method\": \"In vivo microwave exposure model, HIF-1α inhibitor treatment, luciferase reporter for HIF-1α transcriptional activity, Western blot, ATP and ROS measurement, MMP assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — pharmacological HIF-1α inhibition with functional metabolic readouts, single lab\",\n      \"pmids\": [\"29991768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-338 directly targets COX4I1; inhibition of miR-338 increases COX4I1 protein and CcO activity, improving ATP production and cell survival after ischemia/glucose deprivation in astrocytes and neurons. Concurrent siRNA knockdown of COX4I1 abolishes the protective effect, placing COX4I1 downstream of miR-338 in the ischemic injury pathway.\",\n      \"method\": \"miR-338 antagomir/mimic in vivo (MCAO model) and in vitro, CcO activity assay, ATP measurement, siRNA epistasis experiment, infarct size measurement\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo plus in vitro with genetic epistasis (siRNA rescue experiment) confirming COX4I1 as the effector\",\n      \"pmids\": [\"33933660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"COX4I1 depletion in EVT trophoblast cells inhibits proliferation, increases migration and invasion, impairs mitochondrial respiration and glycolysis, and promotes mitochondrial fusion; MMP1 knockdown rescues the increased migration/invasion caused by COX4I1 silencing, placing MMP1 downstream of COX4I1 in trophoblast invasion control.\",\n      \"method\": \"siRNA knockdown, RTCA proliferation/migration/invasion assay, EdU, MitoTracker staining, Seahorse metabolic analysis, siRNA epistasis (MMP1)\",\n      \"journal\": \"Placenta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — multiple functional assays plus epistasis, single lab\",\n      \"pmids\": [\"38718733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"COX4-1 deficiency leads to replicative stress and impaired nuclear DNA damage response: patient fibroblasts and COX4I1-knockdown cells accumulate DNA damage preferentially in proliferating cells, show reduced DNA damage response pathway expression, impaired recovery from genotoxic insult, and decreased DNA repair capacity, leading to premature senescence.\",\n      \"method\": \"Patient fibroblasts (COX4I1 mutation), siRNA knockdown, γH2AX immunofluorescence, DNA damage response gene expression, genotoxin recovery assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — patient cells corroborated by KD model, multiple assays, single lab\",\n      \"pmids\": [\"35456968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CRISPR screen identified COX4I1 as a vulnerability in AML; COX4I1 depletion induces mitochondrial stress and ferroptosis, disrupts mitochondrial ultrastructure and OXPHOS, and synergizes with venetoclax. CRISPR tiling scans coupled with mitochondrial proteomics identified critical regions within COX4I1 essential for complex IV assembly.\",\n      \"method\": \"Cell signaling-focused CRISPR screen, COX4I1 KO/depletion, mitochondrial proteomics, CRISPR gene tiling, in vivo AML xenograft, drug synergy assay (venetoclax + chlorpromazine)\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — orthogonal CRISPR approaches, proteomics, in vivo model, drug combination with functional readouts\",\n      \"pmids\": [\"39716856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human cytochrome c oxidase complex IV contains 14 subunits; cryo-EM structure at 3.3 Å of the human supercomplex I1III2IV1 assigned NDUFA4 as a subunit of complex IV occupying the dimeric interface, demonstrating that the intact complex IV is a monomer. COX4I1 (subunit IV-1) is resolved as part of the complete structure.\",\n      \"method\": \"Cryo-EM structure determination at 3.3 Å from human supercomplex\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure of the intact human complex IV\",\n      \"pmids\": [\"30030519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"COX4I1 (as an early-assembling, presequence-containing subunit) is integrated into cytochrome c oxidase assembly intermediates (MITRAC complexes) via TIM21, which links the TIM23 mitochondrial presequence translocase to respiratory-chain assembly; loss of TIM21 impairs integration of COX4I1-containing subunits into assembly intermediates and regulates mitochondrial protein synthesis in response to assembly state.\",\n      \"method\": \"Comprehensive co-IP/AP-MS of COX assembly intermediates, TIM21 knockdown, pulse-chase metabolic labeling, BN-PAGE\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — AP-MS plus genetic (KD) plus metabolic labeling, multiple orthogonal methods\",\n      \"pmids\": [\"23260140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Arachidonoyl-phosphatidylethanolamine (AA-PE), accumulated in brown adipose tissue mitochondria during cold stress via LPCAT3, partitions at the COX4I1 interface of cytochrome c oxidase; lipid-based proteomics, MD simulations, and bioenergetic analyses show this interaction enhances electron transport chain efficiency and is required for respiratory-dependent thermogenesis.\",\n      \"method\": \"Lipid-based proteomics, molecular dynamics simulations, bioenergetic (ETC) analysis, fat-specific Lpcat3-KO mice, cold acclimation model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches but preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.05.15.654206\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"COX4I1-expressing (transmitochondrial) cybrid cells reconstituted with COX4-1-containing mitochondria restore CcO activity and confer resistance to erastin-induced ferroptosis, instead undergoing apoptosis; COX4-1 cybrids exhibit reduced labile iron, diminished cystine uptake, and low SLC7A11/GPX4 expression, demonstrating that mitochondrial COX4-1 rewires redox metabolism and diverts cell-death signaling from ferroptosis to apoptosis.\",\n      \"method\": \"CRISPR POLG-KO ρ0 cells, transmitochondrial cybrid reconstitution, CcO activity assay, cell death mode analysis, iron measurement, cystine uptake, Western blot for SLC7A11/GPX4\",\n      \"journal\": \"Antioxidants\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — cybrid reconstitution isolates mitochondrial from nuclear contributions, multiple orthogonal mechanistic readouts\",\n      \"pmids\": [\"41596099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cytochrome c oxidase (COX) activity and COX4 protein levels are regulated by reversible phosphorylation downstream of cAMP/PKA and tyrosine kinase signaling, linking cell signaling pathways to COX activity, mitochondrial membrane potential, and ROS/ATP production; identified phosphorylation sites on COX subunits including COX4I1.\",\n      \"method\": \"Phosphoproteomic analysis of COX, kinase/signaling inhibitor studies, crystal-structure mapping of phosphorylation sites\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — phosphoproteomics plus structural mapping and signaling inhibitors; COX4I1-specific phosphorylation data partially inferred from broader COX analysis\",\n      \"pmids\": [\"21771582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A de novo nonsense COX4I1 variant in trans with a deep intronic variant (causing frameshift) primarily reduces COX4I1 protein levels, impairing complex IV assembly and activity. Proteomic analysis of patient fibroblasts also revealed decreased levels of mitoribosomal proteins, suggesting COX4I1 deficiency secondarily affects mitochondrial ribosome homeostasis.\",\n      \"method\": \"Short- and long-read NGS, functional studies in patient tissues and transfected cell lines, complex IV activity assay, mitochondrial proteomics\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional validation in patient cells with molecular and proteomic data, single case\",\n      \"pmids\": [\"41203052\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"COX4I1 encodes the ubiquitous regulatory subunit 4 isoform 1 of mitochondrial cytochrome c oxidase (complex IV); it is essential for complex IV assembly and stability (via zinc coordination in yeast ortholog and early MITRAC-complex integration in humans), optimizes respiratory efficiency through HIF-1-controlled isoform switching (COX4-1 vs. COX4-2) in response to oxygen availability, promotes mitochondrial supercomplex assembly to limit ROS production, interacts with Dynll1 to gate mitochondrial ROS release during bacterial infection, is translationally regulated by mitochondrial lipid composition and polyamines via 5′-UTR stem-loop elements, is targeted by miR-338, and is modulated by AA-PE lipid interaction at its interface on complex IV; loss of COX4I1 causes complex IV deficiency, secondary complex I biogenesis impairment through reduced mitochondrial protein synthesis, replicative stress with impaired DNA damage response, and in cancer cells COX4-1 expression rewires redox metabolism to shift cell death from ferroptosis toward apoptosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"COX4I1 encodes the ubiquitously expressed isoform 1 of cytochrome c oxidase subunit 4, an essential nuclear-encoded regulatory subunit of mitochondrial Complex IV that is required for CcO assembly, activity, ATP production, and mitochondrial supercomplex formation [PMID:28766551, PMID:33578848, PMID:35478774]. COX4I1 binds zinc through conserved cysteine and histidine residues essential for its structural stability and CcO assembly; complete loss of COX4I1 abolishes Complex IV, secondarily impairs Complex I biogenesis and mitochondrial translation, and triggers ferroptosis through altered redox metabolism, while its isoform identity (COX4-1 vs COX4-2) determines supercomplex incorporation, ROS levels, and cell-death pathway selection between ferroptosis and apoptosis [PMID:17215247, PMID:33578848, PMID:39716856, PMID:41596099]. COX4I1 translation is regulated by cardiolipin/phosphatidylglycerol availability via a 5'-UTR stem-loop element and by polyamines, while at the transcriptional level it is controlled by HIF-1α and post-transcriptionally by miR-338 [PMID:16428432, PMID:19695341, PMID:29991768, PMID:33933660]. Biallelic loss-of-function mutations in COX4I1 cause mitochondrial Complex IV deficiency presenting as a Mendelian metabolic disease with impaired oxidative phosphorylation, elevated ROS, and replicative stress [PMID:28766551, PMID:35456968].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"It was unknown how mitochondrial phospholipids influence COX4 expression; discovery of a 5'-UTR cis-element that mediates translational repression in the absence of cardiolipin/phosphatidylglycerol established that COX4 levels are tuned to mitochondrial membrane lipid composition via a specific RNA regulatory element.\",\n      \"evidence\": \"Reporter-fusion 5'-UTR deletion mapping plus RNA–protein binding assays and PGS1 genetic rescue in yeast\",\n      \"pmids\": [\"16428432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the trans-acting repressor protein remains unknown\", \"Whether this lipid-dependent translational control is conserved in mammals has not been tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The structural basis for COX4's role in CcO assembly was undefined; NMR structure determination and mutagenesis showed that zinc binding via conserved Cys/His residues is essential for the subunit's structural integrity and CcO assembly, establishing COX4 as a zinc-dependent scaffold within Complex IV.\",\n      \"evidence\": \"NMR solution structure of yeast Cox4 C-terminal domain combined with site-directed mutagenesis and CcO assembly assays\",\n      \"pmids\": [\"17215247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether zinc occupancy is regulated in vivo is unknown\", \"High-resolution structure of the full mammalian COX4I1 within the CcO holoenzyme was not determined here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The mechanism by which polyamines influence mitochondrial biogenesis was unclear; demonstrating that spermidine stimulates COX4 translation by facilitating ribosome passage over 5'-UTR stem-loops identified COX4 as the first yeast polyamine modulon member, linking polyamine metabolism to oxidative phosphorylation capacity.\",\n      \"evidence\": \"Polyamine-requiring yeast mutant with metabolic labeling and 5'-UTR reporter assays\",\n      \"pmids\": [\"19695341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of ribosome shunting at the molecular level is not resolved\", \"Conservation of polyamine-dependent translational control of COX4I1 in mammalian cells not demonstrated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Whether COX4I1 is essential for human Complex IV function was unproven; identification of a homozygous K101N mutation causing undetectable COX4I1 protein, reduced CcO activity, impaired ATP production, and elevated ROS — rescued by wild-type COX4I1 — established COX4I1 as a disease gene for mitochondrial Complex IV deficiency.\",\n      \"evidence\": \"Patient fibroblast biochemistry with lentiviral wild-type COX4I1 rescue, CcO activity, ATP, and ROS measurements\",\n      \"pmids\": [\"28766551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How K101N specifically destabilizes the protein was not structurally resolved\", \"Full clinical spectrum of COX4I1 deficiency was based on a single family\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Whether the COX4-1 and COX4-2 isoforms confer distinct pharmacological sensitivity to CcO was unknown; showing that chlorpromazine selectively inhibits CcO activity and induces cell cycle arrest only in COX4-1-expressing glioma cells demonstrated isoform-specific CcO kinetic properties with therapeutic implications.\",\n      \"evidence\": \"Enzymatic CcO assay, computational docking, cell cycle analysis in patient-derived glioma stem cells, orthotopic mouse model\",\n      \"pmids\": [\"28455961\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct structural evidence for isoform-specific drug binding site is from docking only\", \"In vivo specificity of chlorpromazine for COX4-1-containing CcO versus off-target effects not fully delineated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The transcriptional regulators of COX4I1 in mammalian cells were poorly defined; showing that HIF-1α inhibition downregulates COX4I1, increases ROS, and collapses mitochondrial membrane potential placed COX4I1 downstream of HIF-1α as part of a protective mitochondrial maintenance axis.\",\n      \"evidence\": \"HIF-1α pharmacological inhibitor in neuron-like cells with ROS, membrane potential, and ATP readouts\",\n      \"pmids\": [\"29991768\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HIF-1α acts directly on the COX4I1 promoter or indirectly was not resolved\", \"Pharmacological inhibitor may have off-target effects\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How mitochondrial ROS release is gated during innate immune responses was unclear; identification of a persistent Dynll1–Cox4i1 complex whose dissociation upon Listeria infection is required for mitochondrial ROS release and bacterial killing revealed a previously unknown physical link between the cytoskeletal motor machinery and Complex IV-dependent ROS regulation.\",\n      \"evidence\": \"Mass spectrometry, Co-IP, Dynll1 genetic depletion, mitochondrial ROS and intracellular bacterial proliferation assays in dendritic cells\",\n      \"pmids\": [\"32041786\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism triggering Dynll1–Cox4i1 dissociation upon infection is unknown\", \"Reciprocal IP or structural validation of the complex not shown\", \"Generalizability beyond Listeria-infected dendritic cells untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The full consequences of COX4I1 loss on the OXPHOS system were incompletely understood; CRISPR knockout in HEK293 cells revealed that loss of Complex IV causes secondary Complex I deficiency, accumulation of Complex I assembly intermediates, and impaired mitochondrial protein synthesis, establishing a functional dependency of Complex I biogenesis on assembled Complex IV.\",\n      \"evidence\": \"CRISPR/Cas9 COX4I1 KO, blue-native PAGE complexome profiling, pulse-chase metabolic labeling of mtDNA-encoded proteins\",\n      \"pmids\": [\"33578848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the Complex I defect is caused by supercomplex loss, impaired translation, or both is not resolved\", \"Whether re-expression of COX4I1 fully rescues Complex I levels was not reported\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Post-transcriptional regulation of COX4I1 in the mammalian nervous system was poorly defined; demonstrating that miR-338 directly targets COX4I1 and that the neuroprotective effect of miR-338 inhibition is abolished by concurrent COX4I1 knockdown established a miR-338→COX4I1→CcO activity axis relevant to ischemic stress.\",\n      \"evidence\": \"miR-338 antagomir in MCAO mouse model, COX4I1 siRNA epistasis, CcO activity and ATP assays in astrocytes and neurons\",\n      \"pmids\": [\"33933660\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct miR-338 binding to the COX4I1 3'-UTR was not validated by luciferase reporter in this study\", \"Contribution of other miR-338 targets not excluded\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Whether COX4-1 is sufficient to drive mitochondrial supercomplex assembly was untested; reciprocal gain- and loss-of-function experiments showed that COX4-1 promotes CcO-containing supercomplex formation, switches metabolism from glycolytic to oxidative, and limits superoxide production, establishing COX4-1 as a determinant of respiratory chain organization.\",\n      \"evidence\": \"COX4-1 overexpression and siRNA silencing in isogenic GBM lines, BN-PAGE, Seahorse respirometry, superoxide measurement\",\n      \"pmids\": [\"35478774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COX4-1 acts directly on supercomplex assembly factors or indirectly through CcO stoichiometry is unknown\", \"In vivo validation of supercomplex effects not performed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Non-bioenergetic consequences of COX4I1 deficiency were largely unexplored; patient fibroblast and knockdown analyses revealed replicative stress and impaired nuclear DNA damage response, broadening the functional scope of COX4I1 beyond oxidative phosphorylation.\",\n      \"evidence\": \"Patient fibroblast analysis, COX4I1 siRNA KD, DNA damage response gene profiling, genotoxic challenge and recovery assays\",\n      \"pmids\": [\"35456968\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DNA damage response impairment is a direct consequence of elevated ROS or involves a separate signaling pathway is unresolved\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The essentiality domains within COX4I1 and the cell-death consequences of its loss in cancer were undefined; CRISPR gene tiling identified critical regions for Complex IV assembly, and COX4I1 depletion in AML cells induced ferroptosis and disrupted mitochondrial ultrastructure, with pharmacological Complex IV inhibition synergizing with venetoclax.\",\n      \"evidence\": \"CRISPR screen and gene tiling, mitochondrial proteomics, electron microscopy, Seahorse respirometry, venetoclax combination in AML cells and in vivo mouse model\",\n      \"pmids\": [\"39716856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise structural explanation for why specific tiled regions are essential awaits high-resolution mutant structures\", \"Whether ferroptosis induction generalizes beyond AML is not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Whether the COX4 isoform identity autonomously determines cell-death pathway choice was unknown; transmitochondrial cybrid reconstitution showed that COX4-1-containing mitochondria confer ferroptosis resistance and redirect cells toward apoptosis by reducing labile iron and suppressing the SLC7A11/GPX4 axis, establishing isoform-specific mitochondrial redox rewiring as a cell-death switch.\",\n      \"evidence\": \"CRISPR POLG-KO ρ0 cells, transmitochondrial cybrid reconstitution with COX4-1 or COX4-2 mitochondria, erastin ferroptosis assay, labile iron and cystine uptake measurements\",\n      \"pmids\": [\"41596099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which COX4-1 suppresses labile iron pool is not defined\", \"Whether isoform-specific cell-death switching occurs in vivo tissues is untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Additional COX4I1 pathogenic variants confirmed the disease gene status and extended the molecular phenotype; patient proteomics revealed downregulation of mitoribosomal proteins alongside Complex IV loss, reinforcing the link between COX4I1 and mitochondrial translation fidelity.\",\n      \"evidence\": \"Patient fibroblast studies with NGS, functional CcO assays, mitochondrial proteomics\",\n      \"pmids\": [\"41203052\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether mitoribosome loss is a direct or indirect consequence of COX4I1 deficiency is unresolved\", \"Number of independent families still limited\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity of the trans-acting translational repressor that binds the COX4 5'-UTR; the structural mechanism by which COX4-1 vs COX4-2 differentially promote supercomplex assembly and rewire redox/cell-death pathways; and whether the Dynll1–COX4I1 interaction and the DNA damage response phenotype represent direct signaling functions of COX4I1 beyond its role as a CcO subunit.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Trans-acting factor mediating cardiolipin-dependent translational control unidentified\", \"No high-resolution structure of human COX4-1 vs COX4-2 in the supercomplex context\", \"Direct vs indirect nature of COX4I1's non-bioenergetic functions (DNA repair, immune ROS) unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 3, 5, 6, 7, 10, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 5, 6, 10, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [10, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 13]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\n      \"Cytochrome c oxidase (Complex IV)\",\n      \"Mitochondrial respiratory supercomplexes\"\n    ],\n    \"partners\": [\n      \"DYNLL1\",\n      \"COX4I2\",\n      \"MMP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"COX4I1 encodes the ubiquitous isoform 1 of subunit 4 of mitochondrial cytochrome c oxidase (complex IV), serving as a nuclear-encoded regulatory subunit essential for complex IV assembly, stability, and respiratory efficiency. Under normoxia COX4-1 is the predominant isoform; hypoxia triggers HIF-1-dependent transcriptional activation of COX4-2 and LON-mediated degradation of COX4-1, switching subunit composition to optimize ATP production and limit ROS [PMID:17418790]. COX4-1 promotes assembly of respiratory supercomplexes, and its complete loss abolishes complex IV, secondarily impairs complex I biogenesis and mitochondrial translation, causes replicative stress with defective DNA damage repair, and in cancer cells rewires redox metabolism to favor apoptosis over ferroptosis [PMID:33578848, PMID:35478774, PMID:35456968, PMID:41596099]. Biallelic loss-of-function mutations in COX4I1 cause cytochrome c oxidase deficiency presenting as mitochondrial disease, confirmed by lentiviral rescue of enzymatic activity in patient fibroblasts [PMID:28766551].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Establishing that COX4 translation is controlled by mitochondrial lipid composition resolved how nuclear-encoded respiratory subunit expression responds to organelle state, revealing a 5′-UTR stem-loop cis-element and a trans-acting cytoplasmic repressor protein active in cardiolipin-deficient yeast.\",\n      \"evidence\": \"Reporter fusions, 5′-UTR deletion mapping, and RNA-binding protein pulldown in pgs1Δ yeast\",\n      \"pmids\": [\"16428432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the cytoplasmic RNA-binding repressor protein was not determined\",\n        \"Whether this translational regulation operates in mammalian cells is unknown\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that HIF-1 coordinately activates COX4-2 and the LON protease to degrade COX4-1 under hypoxia established the first oxygen-responsive isoform-switching mechanism for a respiratory chain subunit, directly linking subunit composition to ATP yield and ROS output.\",\n      \"evidence\": \"Transcriptional reporters, siRNA, overexpression, O₂ consumption, ATP, and ROS assays in mammalian cells\",\n      \"pmids\": [\"17418790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Tissue-specific kinetics and thresholds of the isoform switch in vivo are incompletely defined\",\n        \"Whether post-translational modifications modulate the switching efficiency is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Solving the NMR structure of yeast Cox4 and showing that Zn(II) coordination by conserved Cys/His residues is essential for complex IV assembly provided the first structural basis for the subunit's role in enzyme stability.\",\n      \"evidence\": \"NMR solution structure, site-directed mutagenesis of Zn-ligand residues, yeast complementation\",\n      \"pmids\": [\"17215247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Zn coordination is functionally conserved in human COX4I1 has not been directly tested by mutagenesis\",\n        \"No high-resolution structure of the isolated human COX4I1 subunit exists\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying COX4I1 as an early-assembling subunit integrated via TIM21-mediated coupling of the TIM23 translocase to MITRAC assembly intermediates explained how mitochondrial import is coordinated with respiratory chain biogenesis.\",\n      \"evidence\": \"AP-MS of COX assembly intermediates, TIM21 knockdown, pulse-chase metabolic labeling, BN-PAGE in human cells\",\n      \"pmids\": [\"23260140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Chaperones or factors that specifically stabilize COX4I1 after import but before MITRAC integration are uncharacterized\",\n        \"Structural details of the COX4I1–MITRAC interaction interface are unknown\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of the first pathogenic COX4I1 mutation (K101N) in a patient with cytochrome c oxidase deficiency, rescued by wild-type complementation, established COX4I1 as a Mendelian disease gene for mitochondrial complex IV deficiency.\",\n      \"evidence\": \"Whole-exome sequencing, enzymatic and metabolic assays, lentiviral rescue in patient fibroblasts\",\n      \"pmids\": [\"28766551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Genotype–phenotype spectrum across additional COX4I1 variants is limited to very few patients\",\n        \"Mechanism by which K101N specifically destabilizes the protein (beyond loss of detectable COX4-1) is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The 3.3-Å cryo-EM structure of the human respiratory supercomplex I₁III₂IV₁ placed COX4I1 within the complete 14-subunit complex IV architecture and confirmed that functional complex IV is monomeric within the supercomplex.\",\n      \"evidence\": \"Cryo-EM of purified human mitochondrial supercomplex\",\n      \"pmids\": [\"30030519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How COX4-1 versus COX4-2 incorporation structurally alters the supercomplex interface is not resolved\",\n        \"Dynamic conformational changes of COX4I1 during the catalytic cycle are unknown\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that Dynll1 forms a persistent complex with Cox4i1 and that pathogen-induced dissociation releases mitochondrial ROS to restrict intracellular Listeria revealed an unexpected innate-immune signaling role for complex IV subunit interactions.\",\n      \"evidence\": \"Mass spectrometry, co-immunoprecipitation, Listeria infection in dendritic cells, ROS measurement\",\n      \"pmids\": [\"32041786\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Reciprocal validation (e.g., Cox4i1 bait pulling down Dynll1) and structural mapping of the interaction site are lacking\",\n        \"Whether this mechanism operates for other intracellular pathogens is unknown\",\n        \"How pathogen signals trigger dissociation of the Dynll1–Cox4i1 complex is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CRISPR knockout of COX4I1 demonstrated that its loss not only abolishes complex IV but secondarily impairs complex I biogenesis and mitochondrial translation, revealing an unexpected trans-complex dependency in OXPHOS assembly.\",\n      \"evidence\": \"CRISPR KO in HEK293, BN-PAGE complexome profiling, 35S pulse-chase metabolic labeling\",\n      \"pmids\": [\"33578848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the complex I defect is caused by reduced mitoribosomal function or a specific assembly factor feedback is undefined\",\n        \"Applicability across tissues and in vivo models remains untested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showing that COX4-1 expression drives supercomplex assembly and limits superoxide in glioblastoma cells, conferring radioresistance, linked respiratory chain structural organization to cancer therapy response and identified COX4-1 as a metabolic determinant of treatment sensitivity.\",\n      \"evidence\": \"Isogenic COX4-1 overexpression/silencing, BN-PAGE supercomplex analysis, Seahorse profiling, clonogenic radiation survival\",\n      \"pmids\": [\"35478774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which COX4-1 preferentially promotes supercomplex formation over COX4-2 is unknown\",\n        \"In vivo validation of supercomplex-dependent radioresistance is limited\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that COX4-1-deficient cells accumulate replication-associated DNA damage, show impaired DNA damage response, and enter premature senescence extended COX4I1's role beyond bioenergetics to genome maintenance.\",\n      \"evidence\": \"Patient fibroblasts and siRNA knockdown, γH2AX immunofluorescence, genotoxin recovery, DDR gene expression\",\n      \"pmids\": [\"35456968\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the DNA damage phenotype is a direct consequence of elevated ROS or reduced nucleotide synthesis is unresolved\",\n        \"Single-lab observation awaiting independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A CRISPR screen identifying COX4I1 as an AML vulnerability, with depletion inducing ferroptosis and synergizing with venetoclax, positioned COX4I1-dependent respiration as a druggable node in leukemia and mapped critical assembly-essential regions by gene tiling.\",\n      \"evidence\": \"CRISPR dropout screen, gene tiling, mitochondrial proteomics, in vivo AML xenograft, venetoclax synergy\",\n      \"pmids\": [\"39716856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the ferroptosis phenotype is specific to AML or generalizable across hematologic malignancies is untested\",\n        \"Optimal therapeutic window for pharmacological COX4-1 inhibition has not been defined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Transmitochondrial cybrid reconstitution showed that COX4-1-containing mitochondria rewire redox metabolism—reducing labile iron and suppressing SLC7A11/GPX4—to divert cell death from ferroptosis toward apoptosis, separating mitochondrial from nuclear contributions to this effect.\",\n      \"evidence\": \"CRISPR POLG-KO ρ0 cells, cybrid reconstitution, CcO activity, cell death mode analysis, iron and cystine uptake assays\",\n      \"pmids\": [\"41596099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Signaling pathway linking COX4-1-dependent respiration to SLC7A11/GPX4 down-regulation is uncharacterized\",\n        \"Whether the ferroptosis–apoptosis switch is isoform-specific (COX4-1 vs. COX4-2) under matched conditions is not fully resolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for differential supercomplex assembly by COX4-1 versus COX4-2, the signaling mechanism linking COX4I1 loss to impaired mitochondrial translation and complex I biogenesis, and whether pharmacological targeting of COX4-1-dependent respiration can be therapeutically exploited without on-target toxicity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No isoform-resolved cryo-EM structure comparing COX4-1 and COX4-2 supercomplexes exists\",\n        \"Mechanism coupling COX4I1 deficiency to mitoribosomal protein depletion is undefined\",\n        \"Therapeutic index for COX4-1 pharmacological inhibition in cancer versus normal tissue is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [1, 6, 14, 15]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 4, 8, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1, 6, 14, 15, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 6, 8, 14]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 9, 12]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [6, 15]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [13, 17]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 13, 19]}\n    ],\n    \"complexes\": [\n      \"Cytochrome c oxidase (complex IV)\",\n      \"Respiratory supercomplex I1III2IV1\",\n      \"MITRAC assembly intermediate\"\n    ],\n    \"partners\": [\n      \"DYNLL1\",\n      \"TIM21\",\n      \"COX4I2\",\n      \"NDUFA4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}